# LEQEMBI IQLIK
> **BLA761375** · Biologics License Application · Sponsor: EISAI INC · Approved 2025-08-29
## Drug
- **FDA Application Number:** BLA761375
- **Application type:** Biologics License Application
- **Brand name:** LEQEMBI IQLIK
- **Generic name:** LECANEMAB-IRMB
- **Active ingredients:** LECANEMAB-IRMB
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** EISAI INC
- **Manufacturer:** Eisai Inc.
- **First approval:** 2025-08-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761375)
---
*AI Analytics · CC0 1.0*